Abannan Digital Solutions

Rated 3.67(3) — Abannan Digital Solutions

Hobbs FDR and Lip GYH. Antithrombotic Therapy. New drugs and management strategies - a handbook for clinicians, provides an overview to established and novel therapies for preventing and managing thromboembolic disorders. The handbook provides a backgroun

Rated 0.00(0) — Abannan Digital Solutions

Dyslipidaemia and Atherosclerosis: Clinician's Guidelines Clinical Handbook translates recently updated guidelines for prevention of cardiovascular disease - the ESC/EAS Joint Guidelines for Management of Dyslipidaemia (2016) - to an accessible ready...

Rated 0.00(0) — Abannan Digital Solutions

Targeting Familial Hypercholesterolaemia: EAS Guidance for Detection & Management - Børge G. Nordestgaard, John Chapman, Alberico L.Catapano, Steve E HumphriesFamilial hypercholesterolaemia (FH) – inherited high cholesterol – is one of the most...

Rated 0.00(0) — Abannan Digital Solutions

Cholesterol-rich lipoprotein(a) is a causal factor in atherothrombosis and cardiovascular disease, independent of LDL cholesterol, other lipids, or inflammatory factors. This Handbook, authored by Professors Nordestgaard, Chapman and Ginsberg on behalf...

Rated 0.00(0) — Abannan Digital Solutions

Low density lipoprotein cholesterol (LDL-C) is a major modifiable risk factor driving the development of atherosclerosis and cardiovascular disease (CVD). While statins are effective in lowering LDL-C, attainment of LDL-C goal is problematic in individual

Rated 4.00(1) — Abannan Digital Solutions

Triglyceride-rich lipoproteins and high-density lipoprotein in cardiometabolic disease: Therapeutics old and new - M. John Chapman and Henry N. Ginsberg on behalf of the EAS Consensus Panel. Elevated triglyceride-rich lipoproteins (TRL), for which triglyc

Rated 4.00(6) — Abannan Digital Solutions

This app provides a full listing of everything to see and do at Conference – speeches, sessions, fringe events and exhibitors – and allows you to select “favourites” to plan your personal schedule.Once downloaded, the schedule is available offline...

Rated 0.00(0) — Abannan Digital Solutions

Targeting Familial Hypercholesterolaemia: EAS Guidance for Detection & Management - Børge G. Nordestgaard, John Chapman, Alberico L.Catapano, Steve E HumphriesFamilial hypercholesterolaemia (FH) – inherited high cholesterol – is one of the most...

Rated 5.00(1) — Abannan Digital Solutions

Dyslipidaemia and Atherosclerosis: Clinician's Guidelines Clinical Handbook translates recently updated guidelines for prevention of cardiovascular disease - the ESC/EAS Joint Guidelines for Management of Dyslipidaemia (2016) - to an accessible ready...

Rated 5.00(1) — Abannan Digital Solutions

Cholesterol-rich lipoprotein(a) is a causal factor in atherothrombosis and cardiovascular disease, independent of LDL cholesterol, other lipids, or inflammatory factors. This Handbook, authored by Professors Nordestgaard, Chapman and Ginsberg on behalf...

Rated 0.00(0) — Abannan Digital Solutions

Low density lipoprotein cholesterol (LDL-C) is a major modifiable risk factor driving the development of atherosclerosis and cardiovascular disease (CVD). While statins are effective in lowering LDL-C, attainment of LDL-C goal is problematic in individual